期刊
OTOLARYNGOLOGY-HEAD AND NECK SURGERY
卷 164, 期 1, 页码 117-123出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/0194599820937670
关键词
aquaporin; bumetanide; facial paralysis; regeneration
The study found that after primary neurorrhaphy, dexamethasone and bumetanide alone promoted nerve recovery, but combination therapy was superior.
Objective We investigated the effects of bumetanide alone and in combination with dexamethasone on facial nerve regeneration in rats with facial paralysis. Study Design A prospective controlled animal study. Setting An animal laboratory. Subjects and Methods Facial paralysis was induced in 32 Wistar rats that we then divided into 4 groups: group 1, control; group 2, bumetanide; group 3, dexamethasone; group 4, bumetanide and dexamethasone. Electroneurography was performed 1, 2, and 4 weeks later, and nerve regeneration was evaluated by electron and light microscopy and Western blotting in week 4. Results Regarding the comparison between preoperative values and week 4, the latency difference in group 1 (1.25 milliseconds) was significantly higher than those of groups 2 to 4 (0.56, 0.34, and 0.10 milliseconds, respectively;P= .001). The latency increment in groups 2 and 3 was higher than that of group 4 (P= .002 andP= .046) in week 4, whereas groups 2 and 3 did not differ significantly (P= .291). Amplitude difference was not statistically significant from week 4 among all groups (allP >.05). The number of myelinated axons was significantly higher in all treatment groups than in the control group (P= .001). Axon number and intensity were significantly higher in group 4 as compared with groups 2 and 3 (P= .009,P= .005). Conclusion After primary neurorrhaphy, dexamethasone and bumetanide alone promoted nerve recovery based on electrophysiologic and histologic measures. Combination therapy was, however, superior.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据